Cargando…
Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markers
Emerging evidence suggest migraine is a response to cerebral energy deficiency or oxidative stress in the brain. Beta-hydroxybutyrate (BHB) is likely able to circumvent some of the meta-bolic abnormalities reported in migraine. Exogenous BHB was given to test this assumption and, in this post-hoc an...
Autores principales: | Gross, Elena C., Putananickal, Niveditha, Orsini, Anna-Lena, Schoenen, Jean, Fischer, Dirk, Soto-Mota, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992685/ https://www.ncbi.nlm.nih.gov/pubmed/36882474 http://dx.doi.org/10.1038/s41598-023-28499-y |
Ejemplares similares
-
Mitochondrial function and oxidative stress markers in higher-frequency episodic migraine
por: Gross, Elena C., et al.
Publicado: (2021) -
Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial
por: Putananickal, Niveditha, et al.
Publicado: (2023) -
Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial
por: Gross, Elena, et al.
Publicado: (2019) -
Evaluation of a Clustering Approach to Define Distinct Subgroups of Patients With Migraine to Select Electroacupuncture Treatments
por: Liu, Jixin, et al.
Publicado: (2023) -
Visual evoked potentials in subgroups of migraine with aura patients
por: Coppola, Gianluca, et al.
Publicado: (2015)